Newly revised 2023 MDS response criteria
Blood
.
2023 Apr 27;141(17):2035-2036.
doi: 10.1182/blood.2023019821.
Author
Rafael Bejar
1
Affiliation
1
UC San Diego Health.
PMID:
37103953
DOI:
10.1182/blood.2023019821
No abstract available
Publication types
Editorial
Comment
MeSH terms
Consensus
Humans
Myelodysplastic Syndromes* / diagnosis
Myelodysplastic Syndromes* / therapy
Prognosis